VBAS: Laparoscopic Cholecystectomy Using Airseal in Children

Sponsor
University of Lorraine (Other)
Overall Status
Completed
CT.gov ID
NCT05848726
Collaborator
(none)
23
1
27.3
0.8

Study Details

Study Description

Brief Summary

The goal of this observational study is to compare the use of Airseal versus a standard insufflation, in children who underwent laparoscopic cholecystectomy, between January 2021 and December 2022.

The main questions it aims to answer are:
  • amount of analgesics consumed postoperatively

  • mean digital pain scale

Data are directly extracted from patients medical files.

The investigators will compare the Airseal group (A group) to the Standard insufflation group (S group) to see if the A group consumes significatively less analgesics and are less painful than the S group.

Detailed Description

Choosing to enter the A or the S group depends on the surgeon's choice.

Only the surgeon, the anesthetic and the nurses in the operating room know which type of insufflation has been chosen.

Study Design

Study Type:
Observational
Actual Enrollment :
23 participants
Observational Model:
Other
Time Perspective:
Retrospective
Official Title:
Low-Pressure Laparoscopy Using the Airseal System Versus Standard Insufflation in Cholecystectomy in Children: A Monocentric Retrospective Study
Actual Study Start Date :
Jan 1, 2021
Actual Primary Completion Date :
Dec 31, 2022
Actual Study Completion Date :
Apr 13, 2023

Arms and Interventions

Arm Intervention/Treatment
A Group

Group of patient who underwent laparoscopic cholecystectomy using Airseal

S Group

Group of patient who underwent laparoscopic cholecystectomy using a standard insufflation

Outcome Measures

Primary Outcome Measures

  1. Amount of analgesics consumed [From the end of surgery to the discharge home, up to 20 days]

    Number of takings postoperatively

  2. Mean Digital Pain Scale [From the end of surgery to the discharge home, , up to 20 days]

    Digital Pain Scale: minimum is 0 out of 10 (which means no pain) and maximum is 10 out of 10 (which means very painful). Higher scores mean worse outcomes.

Secondary Outcome Measures

  1. Operating time [Perioperatively]

    Time-length of surgery

  2. Anesthetic time [Perioperatively]

    Time-length of anesthesia

  3. Length of stay [From the day of hospitalization to the day of discharge home, up to 20 days]

    Hospital length of stay

  4. Histological results [between 2 weeks and 4 weeks after surgery]

    Analysis of the gall bladder after removal

Eligibility Criteria

Criteria

Ages Eligible for Study:
N/A to 17 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patients aged under 18 years old

  • Who underwent laparoscopic cholecystectomy

  • From January 2021 to December 2022

Exclusion Criteria:
  • Patients older than 18 years old

Contacts and Locations

Locations

Site City State Country Postal Code
1 ULorraine Vandœuvre-lès-Nancy Grand-Est France 54500

Sponsors and Collaborators

  • University of Lorraine

Investigators

  • Principal Investigator: Christelle Destinval, MD, University of Lorraine

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Dr Christelle DESTINVAL, Principal Investigator, University of Lorraine
ClinicalTrials.gov Identifier:
NCT05848726
Other Study ID Numbers:
  • ULo
  • 2023PI010
First Posted:
May 8, 2023
Last Update Posted:
May 16, 2023
Last Verified:
May 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Dr Christelle DESTINVAL, Principal Investigator, University of Lorraine
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 16, 2023